Biotech · Private company · Branford, CT, US
Abbratech, Inc.
Track this companyFree. Adds Abbratech, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards7
- DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE AbsFiscal year 2026 · $301.2KNIH RePORTER 5R44GM156476-03 · fetched Nov 12, 2026
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12DFiscal year 2025 · $1NIH RePORTER 2R44GM149009-02 · fetched Nov 12, 2026
- DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE AbsFiscal year 2025 · $551.4KNIH RePORTER 4R44GM156476-02 · fetched Nov 12, 2026
- DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE AbsFiscal year 2024 · $205.9KNIH RePORTER 1R44GM156476-01 · fetched Nov 12, 2026
- Structure-guided neutralizing antibodies developed using EpiVolve technologyFiscal year 2024 · $995.8KNIH RePORTER 4R44AI177126-02 · fetched Nov 12, 2026
- Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.Fiscal year 2024 · $1.1MNIH RePORTER 5R44GM146473-03 · fetched Nov 12, 2026
- Platform for the High Throughput Generation and Validation of Affinity ReagentsFiscal year 2024 · $1.1MNIH RePORTER 5R44GM148998-02 · fetched Nov 12, 2026